TY - JOUR
T1 - Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals
T2 - Application to m-iodobenzylguanidine
AU - Vaidyanathan, Ganesan
AU - Zalutsky, Michael R.
AU - DeGrado, Timothy R.
PY - 1998
Y1 - 1998
N2 - Substituting a pyridine ring for a benzene ring in the acylation agent N-succinimidyl 3-iodobenzoate has resulted in a useful approach for the radiohalogenation of monoclonal antibodies, peptides, and labeled biotin conjugates. It was hypothesized that such a substitution in m-iodobenzylguanidine (MIBG), a radiotracer used in the detection and treatment of neuroendocrine tumors, might result in an analogue with more rapid normal tissue clearance, thereby facilitating its use for tumor therapy. For the preparation of this analogue, 3-guanidinomethyl-5-iodopyridine (GMIP; 9b), the silicon precursor 4 was synthesized starting from 5-bromonicotinic acid. Attempts to convert 4 to 9b under various conditions were not successful. Radioiodinated 9b could be prepared by the iododestannylation of the tin precursor 8 in 65-70% radiochemical yield. A number of in vitro, in vivo, and ex vivo studies showed that pyridine-for-benzene substitution in MIBG yielded a compound that no longer was taken up by the uptake-1 pathway.
AB - Substituting a pyridine ring for a benzene ring in the acylation agent N-succinimidyl 3-iodobenzoate has resulted in a useful approach for the radiohalogenation of monoclonal antibodies, peptides, and labeled biotin conjugates. It was hypothesized that such a substitution in m-iodobenzylguanidine (MIBG), a radiotracer used in the detection and treatment of neuroendocrine tumors, might result in an analogue with more rapid normal tissue clearance, thereby facilitating its use for tumor therapy. For the preparation of this analogue, 3-guanidinomethyl-5-iodopyridine (GMIP; 9b), the silicon precursor 4 was synthesized starting from 5-bromonicotinic acid. Attempts to convert 4 to 9b under various conditions were not successful. Radioiodinated 9b could be prepared by the iododestannylation of the tin precursor 8 in 65-70% radiochemical yield. A number of in vitro, in vivo, and ex vivo studies showed that pyridine-for-benzene substitution in MIBG yielded a compound that no longer was taken up by the uptake-1 pathway.
UR - http://www.scopus.com/inward/record.url?scp=0032213077&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032213077&partnerID=8YFLogxK
U2 - 10.1021/bc980037x
DO - 10.1021/bc980037x
M3 - Article
C2 - 9815170
AN - SCOPUS:0032213077
SN - 1043-1802
VL - 9
SP - 758
EP - 764
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 6
ER -